Bioidentical Hormone Therapy

Bioidentical hormones may interact with certain drugs like blood thinners or antidepressants; always share your complete medication list with your provider for a personalized review to ensure safety.

Many use it ongoing with regular check-ins, as studies suggest sustained balance can support wellness; periodic evaluations help adjust for life changes like aging or stress  The FDA has recently The FDA has announced that it is initiating removal of the broad “black box” warnings from many menopausal HRT products. These warnings previously linked hormone therapies to elevated risks of heart attack, stroke, breast cancer and dementia. U.S. Food and Drug Administration+2HHS+2

The change reflects updated evidence showing that when hormone therapy is started earlier (generally within ten years of menopause onset or before age 60), many of the risks previously assumed are lower and/or the balance of benefits may shift.

https://www.hhs.gov/press-room/fact-sheet-fda-initiates-removal-of-black-box-warnings-from-menopausal-hormone-replacement-therapy-products.html

While often explored in midlife for perimenopause or andropause, younger adults with confirmed imbalances may benefit; lab testing determines the best timing.  The FDA recommends to start Hormone Replacement Therapy (HRT) within 10 years of menopause onset or before age 60.  However, HRT can be started sooner as symptoms appear.